Skip to Content

Afluria Quadrivalent FDA Approval History

FDA Approved: Yes (First approved August 26, 2016)
Brand name: Afluria Quadrivalent
Generic name: influenza virus vaccine, inactivated
Dosage form: Injection
Company: Seqirus
Treatment for: Influenza Prophylaxis

Afluria Quadrivalent is an inactivated influenza virus vaccine indicated for active immunization against influenza disease in persons 6 months of age and older.

Development Timeline for Afluria Quadrivalent

DateArticle
Oct 23, 2018ApprovalSeqirus Receives FDA Approval of Afluria and Afluria Quadrivalent (Influenza Vaccine) for People Six Months of Age and Older in the U.S.
Sep 14, 2017ApprovalSeqirus Receives FDA Approval of Afluria Quadrivalent (Influenza Vaccine) for People Five Years of Age and Older in the U.S.
Aug 29, 2016ApprovalSeqirus Receives FDA Approval for Afluria Quadrivalent (Influenza Vaccine) for People 18 Years of Age and Older

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.